The global Rare Biomarkers Specimen Collection Stabilization Market was valued at USD 609.9 Million in 2022, and it is projected to reach USD 1983.36 Million by 2032, exhibiting a robust revenue CAGR of 14% throughout the forecast period. The substantial growth in market revenue can be attributed to several key factors, including the escalating prevalence of chronic illnesses, a rising demand...
0 Commentarios
0 Acciones
636 Views
0 Vista previa